BiondVax Pharmaceuticals ... (BVXV)
NASDAQ: BVXV
· Real-Time Price · USD
1.36
0.01 (0.74%)
At close: Sep 06, 2023, 9:59 PM
BiondVax Pharmaceuticals Income Statement
Financials in ILS. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 2.75M | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | 2.02M | n/a | n/a | n/a | n/a | 2.75M | n/a | n/a | n/a |
Operating Income | -2.6M | -3.19M | -6.8M | 3.87M | -10.78M | -8.29M | -10.94M | -8.22M | -8.9M | -6.75M |
Interest Income | n/a | n/a | 2.79M | 6.04M | 1.57M | 1.21M | -2.8M | 1.98M | n/a | 1.18M |
Pretax Income | -3.76M | -3.52M | -600K | 3.75M | -12.85M | -9.42M | -10.75M | -9.05M | -11.99M | -8.19M |
Net Income | -3.76M | -3.84M | 5.6M | 9.79M | -12.85M | -9.42M | -10.75M | -9.05M | -11.99M | -8.19M |
Selling & General & Admin | 1.14M | 1.19M | 1.86M | 3.34M | 4.29M | 4.63M | 6.77M | 6.2M | 7M | 4M |
Research & Development | 1.45M | 2M | 1.8M | 3.99M | 6.5M | 3.65M | 3.66M | 2.02M | 1.9M | 2.75M |
Other Expenses | n/a | n/a | 3.14M | -11.2M | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.6M | 3.19M | 6.8M | -3.87M | 10.78M | 8.29M | 10.94M | 8.22M | 8.9M | 6.75M |
Interest Expense | n/a | 329K | n/a | 6.17M | 3.64M | 2.34M | 2.69M | 2.8M | 3.09M | 2.61M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.6M | 3.19M | 6.8M | -3.87M | 10.78M | 8.29M | 10.94M | 8.22M | 8.9M | 6.75M |
Income Tax Expense | n/a | 329K | -6.2M | -6.04M | -778K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.38M | 3.24M | 1.94M | 1.87M | 1.87M | 1.86M | 1.64M | 1.43M | 1.43M | 1.33M |
Shares Outstanding (Diluted) | 3.38M | 3.24M | 1.94M | 1.87M | 1.87M | 1.86M | 1.64M | 1.43M | 1.43M | 1.33M |
EPS (Basic) | -1.11 | -1.19 | -1.76 | 5.24 | -6.47 | -5.06 | -6.57 | -6.31 | -8.37 | -6.17 |
EPS (Diluted) | -1.11 | -1.19 | -1.76 | 5.24 | -6.47 | -5.06 | -6.57 | -6.31 | -8.37 | -6.17 |
EBITDA | -2.6M | -3.05M | -9.27M | 9.91M | -8.43M | -7.07M | -7.47M | -5.63M | -8.3M | -5.57M |
EBIT | n/a | -3.19M | -6.8M | 9.91M | -9.21M | -7.07M | -8.06M | -6.25M | -8.9M | -5.57M |
Depreciation & Amortization | 147K | 138K | -2.48M | 6.04M | 778K | 1.21M | 594K | 612K | 604K | 1.18M |